Yushen Qian, MD
Radiation Oncology · Stanford, CANPI 1093154395
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $46,550 of the $46,626 with a category attached, or 99.8%. Modernatx, Inc. accounts for 99.8% of it on its own, with 2 other manufacturers making up the rest. 2023 is the largest year on record at $46,584, more than ten times the $16 reported in 2019. Among radiation oncology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 18 payments — averaging $2590.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$47K
- Novocure Inc.$42
- GT Medical Technologies, Inc$34
What the payments were for
- Consulting fees$46,550100%
- Food & beverage$760%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 14 | $46,550 |
| Novocure Inc. | 3 | $42 |
| GT Medical Technologies, Inc | 1 | $34 |
How this compares
$46,626 in reported general payments places this provider in the 95th percentile of 627 radiation oncology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 112 | $1,730 |
| Gabapentin | 43 | $940 |
| Lidocaine Hcl ViscousLidocaine Hcl | 11 | $216 |
| Omeprazole | 14 | $140 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Stanford
- Maximilian DiehnStanford$73K
- Anusha KalbasiStanford$37K
- Rishabh ChaudhariStanford$35K
- Quynh-Thu leStanford$23K
- Scott SoltysStanford$19K
- Noah Kastelowitz-LiebermanStanford$17K
- Billy LooStanford$11K
- Rakesh PatelLos Gatos$1.3M
- Amir LavafPalm Springs$411K
- Albert ChangLos Angeles$290K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.